Newbridge Financial Services Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5
| Closed | -$5 | – | 1162 |
|
|
2024
Q3 | $5 | Hold |
5
| – | – | ﹤0.01% | 652 |
|
|
2024
Q2 | $5 | Hold |
5
| – | – | ﹤0.01% | 1079 |
|
|
2024
Q1 | $7 | Hold |
5
| – | – | ﹤0.01% | 1169 |
|
|
2023
Q4 | $5 | Hold |
5
| – | – | ﹤0.01% | 1115 |
|
|
2023
Q3 | $6 | Hold |
5
| – | – | ﹤0.01% | 1278 |
|
|
2023
Q2 | $7 | Hold |
5
| – | – | ﹤0.01% | 1342 |
|
|
2023
Q1 | $8 | Hold |
5
| – | – | ﹤0.01% | 1401 |
|
|
2022
Q4 | $6 | Hold |
5
| – | – | ﹤0.01% | 1434 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 1433 |
|
|
2022
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1448 |
|